Research Applications of Tamoxifen Citrate
Nolvadex Dragon Pharma is a pharmaceutical-grade tamoxifen citrate formulation manufactured for advanced laboratory research into selective estrogen receptor modulation. As a non-steroidal SERM, this compound serves as a valuable reference standard when investigating competitive estrogen receptor antagonism in breast tissue models while examining potential agonist activity in bone and endometrial research systems. Researchers studying estrogen-dependent pathways will find this preparation particularly useful for evaluating receptor binding dynamics and downstream signalling cascades in controlled laboratory environments.
Scientists conducting hormonal research can examine this compound’s well-documented mechanism of action as a competitive antagonist at estrogen receptors. The formulation enables researchers to study tissue-selective estrogen receptor modulation, making it an essential tool for laboratories investigating endocrine disruption, breast cancer cell lines, and hormonal pathway interactions. When sourced from Stroid UK Shop, researchers gain access to pharmaceutical-grade materials suitable for demanding research protocols requiring consistent compound quality and purity verification.
Laboratory Research Mechanisms
In research settings, tamoxifen citrate demonstrates complex pharmacodynamics that researchers can evaluate across multiple tissue types. The compound’s ability to function as both an antagonist and partial agonist depending on tissue context makes it particularly valuable for studying selective estrogen receptor modulation pathways. Researchers examining aromatase inhibitors and related compounds often utilise this reference standard to understand competitive receptor binding mechanisms in various cellular models.
Laboratory studies can investigate this compound’s interaction with estrogen receptor alpha and beta subtypes, examining differential tissue responses in controlled experimental conditions. The pharmaceutical formulation enables precise dosing calculations for in-vitro studies, while its established pharmacokinetic profile provides researchers with comprehensive background data for experimental design. Scientists studying selective androgen receptor modulators may also find this compound useful for comparative receptor selectivity studies, while those investigating peptide research compounds can examine potential synergistic or antagonistic interactions in complex hormonal pathway research.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Tamoxifen Citrate |
| CAS Number | 54965-24-1 |
| Molecular Formula | C₃₂H₃₇NO₈ |
| Molecular Weight | 563.64 g/mol |
| Storage Requirements | Room temperature, protect from light |
| Manufacturer | Dragon Pharma |
| Research Grade | Pharmaceutical standard |
Research Compliance Statement
This tamoxifen citrate preparation is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure appropriate laboratory safety protocols, proper waste disposal procedures, and compliance with institutional research guidelines when handling this compound. All research activities should be conducted by qualified personnel in appropriate laboratory facilities with proper ventilation and safety equipment.
